Utilize este identificador para referenciar este registo: https://hdl.handle.net/10216/155557
Registo completo
Campo DCValorIdioma
dc.creatorMartins, C-
dc.creatorPacheco, C-
dc.creatorFaria, P-
dc.creatorSarmento, B-
dc.date.accessioned2023-12-07T13:38:57Z-
dc.date.available2023-12-07T13:38:57Z-
dc.date.issued2023-08-18-
dc.identifier.issn1743-5889-
dc.identifier.urihttps://hdl.handle.net/10216/155557-
dc.description.sponsorshipThis work was supported by the project Norte-01-0145-FEDER-000051 – “Cancer Research on Therapy Resistance: From Basic Mechanisms to Novel Targets”, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development und (FEDER) and FCT – Fundação para a Ciência e a Tecnologia. CP and PF thank FCT for financial support (Grants SFRH/BD/06611/2020 and SFRH/BD/06709/2021, respectively). This work has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 951723.pt_PT
dc.language.isoengpt_PT
dc.publisherFuture Medicinept_PT
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/951723/EUpt_PT
dc.relation.ispartofseriesNanomedicine, vol.18(18), p. 1135-1138pt_PT
dc.rightsembargoedAccesspt_PT
dc.subjectAngiogenesispt_PT
dc.subjectDrug deliverypt_PT
dc.subjectGlioblastomapt_PT
dc.subjectLocal therapiespt_PT
dc.subjectNanomedicinept_PT
dc.subjectTargetingpt_PT
dc.titleNanomedicine approaches for treating glioblastomapt_PT
dc.typeArtigo em Revista Científica Internacionalpt_PT
dc.date.embargo2024-08-18-
dc.contributor.uportoInstituto de Investigação e Inovação em Saúdept_PT
dc.identifier.doi10.2217/nnm-2023-0163-
dc.relation.publisherversionhttps://www.futuremedicine.com/doi/10.2217/nnm-2023-0163-
Aparece nas coleções:I3S - Artigo em Revista Científica Internacional

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
NNM-2023-0163-initial-revisions_REVISED.pdf215.09 kBAdobe PDFThumbnail
Ver/Abrir


Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.